Best Value Stocks to Buy for June 29th

The article highlights three Zacks Rank #1 stocks with improving earnings estimates and value characteristics: Daktronics (+8.3% current-year EPS estimate over 60 days), ORIX (+68.7% current-year EPS estimate), and TD SYNNEX (+4.2% next-year EPS estimate). All three trade at below-market or below-industry P/E multiples and carry Value Scores of A or B, indicating favorable fundamentals. This is stock-screening commentary rather than a company-specific catalyst, so near-term market impact is likely limited.

Analysis

The common thread here is not “cheap stocks,” but earnings revision momentum in businesses where operating leverage can still expand faster than multiples. The most interesting setup is IX: if the estimate reset is real, the market is likely underestimating how much of that improvement is cyclical rather than structural, which matters because a large beat can keep driving multiple expansion for several quarters even in a modest macro slowdown. SNX is the cleaner quality/value name, but it is more of a late-cycle implementation beneficiary than a true re-rating story.

DAKT looks like the most second-order-sensitive name: any improvement in project timing or municipal/commercial capex can translate into outsized margin upside because fixed costs are already in place. The flip side is that this is the easiest name for the market to fade if order timing slips by even one quarter, so the reward is high but the path is choppy. In contrast, SNX’s risk is less about demand collapse and more about inventory normalization; if channel conditions stabilize, the downside may be capped, but upside can be muted unless management proves operating discipline.

The consensus appears to be missing how much of the value case depends on estimates staying stable rather than just “cheapness.” In other words, these are not deep value traps, but they are also not durable compounders if revision momentum stalls. The real catalyst window is the next 1-2 earnings cycles: if estimates keep moving up, these stocks can work even without multiple expansion; if they flatten, the market will likely compress them back to peer averages quickly.

Key Decisions for Investors

• Long IX vs. broad financials for 1-2 quarters: seek upside from continued estimate revisions, with a stop if the next earnings update fails to confirm momentum.
• Initiate a tactical long in DAKT ahead of the next print only if positioning is light; use a tight risk budget because the name is highly sensitive to project timing and can give back gains quickly on any guidance slip.
• Own SNX as the highest-quality value exposure in the group for a 3-6 month horizon; pair it against a higher-beta IT distributor or hardware name if you want to isolate valuation support from end-demand noise.
• If chasing the basket, size IX > SNX > DAKT: IX offers the strongest revision upside, SNX the best downside protection, and DAKT the most binary event risk.